Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer – A review

Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer – A review

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease, projected to rank as the second most prevalent cause of cancer-related mortality by 2030. Despite significant progress in advances in surgical techniques and chemotherapy protocols, the overall survival (OS) remains to be less than 10...

Full description

Bibliographic Details
Main Authors:	Suna Erdem, Jayanth Shankara Narayanan, Mathias Worni, Martin Bolli, Rebekah R. White
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Heliyon
Subjects:	Pancreatic cancer Locally advanced pancreatic cancer local ablative techniques Immune modulation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023107596

Similar Items

Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies
by: Alette Ruarus, et al.
Published: (2018-01-01)

Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm?
by: Nicola Simoni, et al.
Published: (2022-03-01)

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial
by: M. S. Walma, et al.
Published: (2021-04-01)

Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols
by: Govindarajan Narayanan, et al.
Published: (2021-07-01)

Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies
by: Eran van Veldhuisen, et al.
Published: (2019-07-01)

Commentary on Pancreatic Carcinoma: The Role of Radiofrequency Ablation in Advanced Disease
by: John Spiliotis
Published: (2010-12-01)

Radiation therapy in locally advanced pancreatic cancer with 75 Gy simultaneous integrated boost: a dosimetric feasibility study
by: ZHUANG Han, LING Chifang, WANG Jiazhou, HAN Xu, JIANG Rui, HU Weigang
Published: (2023-01-01)

Endoscopic Ultrasound-Guided Pancreatic Interstitial Laser Ablation Using a Cylindrical Laser Diffuser: A Long-Term Follow-Up Study
by: Jungnam Lee, et al.
Published: (2022-11-01)

Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial
by: Jakob Liermann, et al.
Published: (2022-05-01)

Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
by: Changhoon Yoo, et al.
Published: (2019-02-01)

The Pre-Ablation Circulating Tumor-Associated Inflammatory Index Predicts the Prognosis of Patients with Liver Metastasis from Pancreatic Cancer
by: Li Y, et al.
Published: (2022-10-01)

Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?
by: Luís Filipe Abreu de Carvalho, et al.
Published: (2023-09-01)

Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer
by: Masahiko Okamoto, et al.
Published: (2021-02-01)

Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer
by: Yoko Goto, et al.
Published: (2018-06-01)

A 15-Year Single-Institution Retrospective Study of Primary Pancreatic Cancer Treated with Non-Ablative Palliative Radiotherapy
by: Randa Kamel, et al.
Published: (2024-02-01)

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
by: Mariia Kiriukova, et al.
Published: (2020-09-01)

Conversion Surgery for Pancreatic Cancer—The Impact of Neoadjuvant Treatment
by: Ulla Klaiber, et al.
Published: (2020-01-01)

An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer
by: Junming Huang, et al.
Published: (2023-04-01)

Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic Cancer
by: Alejandra Vargas, et al.
Published: (2024-03-01)

Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer
by: Stefano Lafranceschina, et al.
Published: (2019-11-01)

Ablation in Pancreatic Cancer: Past, Present and Future
by: Govindarajan Narayanan, et al.
Published: (2021-05-01)

Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar
by: Renzo Mazzarotto, et al.
Published: (2020-12-01)

Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement—A retrospective study
by: Lihan Qian, et al.
Published: (2023-12-01)

Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study
by: Jonathan Garnier, et al.
Published: (2020-03-01)

Irreversible Electroporation (IRE) in Locally Advanced Pancreatic Cancer: A Review of Current Clinical Outcomes, Mechanism of Action and Opportunities for Synergistic Therapy
by: Zainab L. Rai, et al.
Published: (2021-04-01)

Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation
by: Hester J. Scheffer, et al.
Published: (2019-11-01)

Sequential Irreversible Electroporation for Locally Advanced Pancreatic Cancer
by: Daniel Yuxuan Ong, et al.
Published: (2023-11-01)

Advances in Radiation Oncology for Pancreatic Cancer: An Updated Review
by: Jason Liu, et al.
Published: (2022-11-01)

Advancements in Microwave Ablation Techniques for Managing Pancreatic Lesions
by: Devarshi R. Ardeshna, et al.
Published: (2023-11-01)

Current Surgical Aspects of Palliative Treatment for Unresectable Pancreatic Cancer
by: Konstantinos Karapanos, et al.
Published: (2011-02-01)

Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma
by: Sabrina Gloria Giulia Testoni, et al.
Published: (2023-07-01)

Local Ablative Therapy Associated with Immunotherapy in Locally Advanced Pancreatic Cancer: A Solution to Overcome the Double Trouble?—A Comprehensive Review
by: Jonathan Garnier, et al.
Published: (2022-03-01)

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)
by: Tiziana Comito, et al.
Published: (2023-07-01)

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
by: Marco Massani, et al.
Published: (2023-01-01)

Long-term survival after esophagectomy with distal pancreatectomy for locally advanced esophageal cancer with pancreatic invasion: a case report
by: Yoshiki Kaneko, et al.
Published: (2021-12-01)

Application of stereotactic body radiotherapy in advanced pancreatic cancers in Australia
by: Laurence Kim, et al.
Published: (2019-03-01)

Endoscopic Ultrasound-Guided Local Therapy for Pancreatic Neoplasms
by: Jun Seong Hwang, et al.
Published: (2020-09-01)

Management of Advanced Pancreatic Cancer through Stromal Depletion and Immune Modulation
by: Tiantong Liu, et al.
Published: (2022-09-01)

Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX
by: Jin Ho Choi, et al.
Published: (2022-09-01)

Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity
by: Christy Goldsmith, et al.
Published: (2018-10-01)